Historique
Bulletin de Périodique
Drug Testing and Analysis , Vol.8, n°7-8 - July-August 2016
Paru le :
01/08/2016
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013. Baume N., Geyer H., Vouillamoz M., Grisdale R., Earl M., Aguilera R., et al., p. 603-612.
- Detection and metabolic investigations of a novel designer steroid: 3-chloro-17alpha-methyl-5alpha-androstan-17beta-ol. Cawley A.T., Blakey K., Waller C.C., McLeod M.D., Boyd S., Heather A., et al., p. 621-632.
- Effectiveness of saliva and fingerprints as alternative specimens to urine and blood in forensic drug testing. Kuwayama K., Miyaguchi H., Yamamuro T., Tsujikawa K., Kanamori T., Iwata Y.T., et al., p. 644-651.
- Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Adamowicz P., Tokarczyk B., p. 652-667.
- A simple and rapid method for the determination of nicotine in third-hand smoke by liquid chromatography and its application for the assessment of contaminated outdoor communal areas. Santos e Silva S.I., Bowdler P., Giltrow D., Riddell S., Honeychurch K.C., p. 676-681.
- Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Karschner E.L., Swortwood M.J., Hirvonen J., Goodwin R.S., Bosker W.M., Ramaekers J.G., et al., p. 682-689.
- Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Hartman R.L., Brown T.L., Milavetz G., Spurgin A., Gorelick D.A., Gaffney G., et al., p. 690-701.
- Estimates of tobacco use by wastewater analysis of anabasine and anatabine. Tscharke B.J., White J.M., Gerber J.P., p. 702-707.
- Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS. Berg T., Kaur L., Risnes A., Havig S.M., Karinen R., p. 708-722.
- The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies. de la Peña J.B., Cheong J.H., p. 760-767.
- What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties. Rychert M., Wilkins C., p. 768-778.
- Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines. Wallach J., Colestock T., Cicali B., Elliott S.P., Kavanagh P.V., Adejare A., et al., p. 801-815.
- Identification of polymorphism in ethylone hydrochloride: synthesis and characterization. Maheux C.R., Alarcon I.Q., Copeland C.R., Cameron T.S., Linden A., Grossert J.S., p. 847-857.
- Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption. Joya X., Marchei E., Salat-Batlle J., García-Algar O., Calvaresi V., Pacifici R., et al., p. 864-868.
- Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013. Baume N., Geyer H., Vouillamoz M., Grisdale R., Earl M., Aguilera R., et al., p. 603-612.
- Detection and metabolic investigations of a novel designer steroid: 3-chloro-17alpha-methyl-5alpha-androstan-17beta-ol. Cawley A.T., Blakey K., Waller C.C., McLeod M.D., Boyd S., Heather A., et al., p. 621-632.
- Effectiveness of saliva and fingerprints as alternative specimens to urine and blood in forensic drug testing. Kuwayama K., Miyaguchi H., Yamamuro T., Tsujikawa K., Kanamori T., Iwata Y.T., et al., p. 644-651.
- Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Adamowicz P., Tokarczyk B., p. 652-667.
- A simple and rapid method for the determination of nicotine in third-hand smoke by liquid chromatography and its application for the assessment of contaminated outdoor communal areas. Santos e Silva S.I., Bowdler P., Giltrow D., Riddell S., Honeychurch K.C., p. 676-681.
- Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Karschner E.L., Swortwood M.J., Hirvonen J., Goodwin R.S., Bosker W.M., Ramaekers J.G., et al., p. 682-689.
- Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Hartman R.L., Brown T.L., Milavetz G., Spurgin A., Gorelick D.A., Gaffney G., et al., p. 690-701.
- Estimates of tobacco use by wastewater analysis of anabasine and anatabine. Tscharke B.J., White J.M., Gerber J.P., p. 702-707.
- Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS. Berg T., Kaur L., Risnes A., Havig S.M., Karinen R., p. 708-722.
- The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies. de la Peña J.B., Cheong J.H., p. 760-767.
- What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties. Rychert M., Wilkins C., p. 768-778.
- Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines. Wallach J., Colestock T., Cicali B., Elliott S.P., Kavanagh P.V., Adejare A., et al., p. 801-815.
- Identification of polymorphism in ethylone hydrochloride: synthesis and characterization. Maheux C.R., Alarcon I.Q., Copeland C.R., Cameron T.S., Linden A., Grossert J.S., p. 847-857.
- Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption. Joya X., Marchei E., Salat-Batlle J., García-Algar O., Calvaresi V., Pacifici R., et al., p. 864-868.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
P. ADAMOWICZ ;
B. TOKARCZYK
|
2016
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
In recent years, many new psychoactive substances (NPS) from several drug classes have appeared on the drug market. These substances, also known as 'legal highs', belong to different chemical classes. Despite the increasing number of NPS, there [...]
B. J. TSCHARKE ;
J. M. WHITE ;
J. P. GERBER
|
2016
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
Wastewater analysis, the chemical analysis of municipal sewage, is fast becoming the technique of choice to monitor changes in community consumption of a range of compounds over time. Currently wastewater analyses which estimate tobacco consumpt[...]
M. RYCHERT ;
C. WILKINS
|
2016
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
The problem of defining what psychoactive products and substances should be covered by legislation aimed at controlling new psychoactive substances (NPS; 'legal highs') is central to the current debate on designing new legislative responses to N[...]
X. JOYA ;
E. MARCHEI ;
J. SALAT-BATLLE ;
O. GARCIA-ALGAR ;
V. CALVARESI ;
R. PACIFICI ;
S. PICHINI
|
2016
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
Dans Drug Testing and Analysis (Vol.8, n°7-8, July-August 2016) Article : Périodique
In a prospective sample of 80 mother-infant dyads, we investigated whether drugs of abuse in maternal hair measured during the pregnancy trimesters were also present in neonatal meconium. Principal drugs of abuse were analyzed in the three conse[...]